Literature DB >> 18374949

Cerebellar ataxia in non-paraneoplastic Lambert-Eaton myasthenic syndrome.

Paulo J Lorenzoni1, Rosana H Scola, Bethan Lang, Claudia S K Kay, Helio A G Teive, Pedro A Kowacs, Lineu C Werneck.   

Abstract

Lambert-Eaton myasthenic syndrome (LEMS) is an immune-mediated disorder of the neuromuscular junction that rarely is associated with cerebellar ataxia (CA). We describe two patients with non-paraneoplastic LEMS associated with CA who showed high levels of anti-P/Q-type voltage-gated calcium channels antibodies in the serum and cerebrospinal fluid, and reduced CMAP with increment after brief maximum voluntary contraction in electrophysiological studies. We suggest that LEMS should be considered in the differential diagnosis of patients with CA.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18374949     DOI: 10.1016/j.jns.2008.02.004

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  5 in total

Review 1.  Neuronal central nervous system syndromes probably mediated by autoantibodies.

Authors:  Aude Chefdeville; Jérôme Honnorat; Christiane S Hampe; Virginie Desestret
Journal:  Eur J Neurosci       Date:  2016-03-28       Impact factor: 3.386

Review 2.  Voltage gated calcium channel antibody-related neurological diseases.

Authors:  Can Ebru Bekircan-Kurt; Eda Derle Çiftçi; Aslı Tuncer Kurne; Banu Anlar
Journal:  World J Clin Cases       Date:  2015-03-16       Impact factor: 1.337

3.  Lambert-eaton myasthenic syndrome; pathogenesis, diagnosis, and therapy.

Authors:  Nils Erik Gilhus
Journal:  Autoimmune Dis       Date:  2011-09-29

4.  Voltage-gated calcium channel autoimmune cerebellar degeneration: Case and study of cytotoxicity.

Authors:  Marilyn McKasson; Stacey L Clardy; Susan A Clawson; Kenneth E Hill; Blair Wood; Noel Carlson; Mark Bromberg; John E Greenlee
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2016-03-31

5.  Antibody repertoire in paraneoplastic cerebellar degeneration and small cell lung cancer.

Authors:  Lidia Sabater; Romana Höftberger; Anna Boronat; Albert Saiz; Josep Dalmau; Francesc Graus
Journal:  PLoS One       Date:  2013-03-25       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.